Login / Signup

Oral Health-Related Quality of Life in Rare Disorders of Congenital Facial Weakness.

Denise K LibertonKonstantinia AlmpaniRashmi MishraCarol BassimCarol Van Ryzinnull On Behalf Of The Moebius Syndrome Research ConsortiumBryn D WebbEthylin Wang JabsElizabeth C EngleFrancis S CollinsIrini ManoliJanice S Lee
Published in: International journal of environmental research and public health (2024)
Congenital facial weakness (CFW) encompasses a heterogenous set of rare disorders presenting with decreased facial movement from birth, secondary to impaired function of the facial musculature. The aim of the present study is to provide an analysis of subject-reported oral health-related quality of life (OHRQoL) in congenital facial weakness (CFW) disorders. Forty-four subjects with CFW and age- and sex- matched controls were enrolled in an Institutional Review Board (IRB)-approved study. Demographic data, medical and surgical history, comprehensive oral examination, and the Oral Health Impact Profile (OHIP-14) were obtained. Compared to unaffected controls, subjects with CFW had higher OHIP-14 scores overall (mean ± SD: 13.11 ± 8.11 vs. 4.46 ± 4.98, p < 0.0001) and within five of seven oral health domains, indicating decreased OHRQoL. Although subjects with Moebius syndrome (MBS) were noted to have higher OHIP-14 scores than those with Hereditary Congenital Facial Paresis (HCFP), there was no significant correlation in OHIP-14 score to age, sex, or specific diagnosis. An increase in OHIP-14 scores in subjects was detected in those who had undergone reanimation surgery. In conclusion, subjects with CFW had poorer OHRQoL compared to controls, and subjects with MBS had poorer OHRQoL than subjects with HCFP. This study provides better understanding of oral health care needs and quality of life in a CFW cohort and suggests that guidelines for dental treatment are required.
Keyphrases
  • oral health
  • healthcare
  • minimally invasive
  • machine learning
  • electronic health record
  • atrial fibrillation
  • acute coronary syndrome
  • combination therapy